Harbin Pharmaceutical Group Co Ltd (600664) — Net Asset Quality Index

Latest as of September 2025: 45.5%

Harbin Pharmaceutical Group Co Ltd (600664) has a Net Asset Quality Index of 45.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥14.08 Billion minus total liabilities of CN¥7.67 Billion yields net assets of CN¥6.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Harbin Pharmaceutical Group Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

45.5%
Equity / Total Assets

Net Assets

CN¥6.41 Billion
CNY

Total Assets

CN¥14.08 Billion
CNY

Total Liabilities

CN¥7.67 Billion
CNY

Harbin Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (1993–2024)

This chart shows how Harbin Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 32 annual periods from 1993 to 2024. As of September 2025, the index stands at 45.5%, representing net assets of CN¥6.41 Billion against total assets of CN¥14.08 Billion CNY. See 600664 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Harbin Pharmaceutical Group Co Ltd (1993–2024)

The table below presents the year-by-year Net Asset Quality Index for Harbin Pharmaceutical Group Co Ltd from 1993 to 2024, covering 32 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Harbin Pharmaceutical Group Co Ltd.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 41.7% CN¥6.09 Billion CN¥14.62 Billion CN¥8.53 Billion ▲ +3.2 pp
2023 38.4% CN¥5.42 Billion CN¥14.11 Billion CN¥8.69 Billion ▲ +1.6 pp
2022 36.8% CN¥4.95 Billion CN¥13.44 Billion CN¥8.48 Billion ▲ +2.4 pp
2021 34.4% CN¥4.42 Billion CN¥12.84 Billion CN¥8.42 Billion ▲ +0.8 pp
2020 33.7% CN¥3.99 Billion CN¥11.85 Billion CN¥7.86 Billion ▼ -13.9 pp
2019 47.5% CN¥5.94 Billion CN¥12.50 Billion CN¥6.56 Billion ▼ -5.2 pp
2018 52.8% CN¥6.28 Billion CN¥11.90 Billion CN¥5.62 Billion ▼ -1.8 pp
2017 54.6% CN¥7.48 Billion CN¥13.70 Billion CN¥6.22 Billion ▼ -0.5 pp
2016 55.1% CN¥8.30 Billion CN¥15.05 Billion CN¥6.75 Billion ▲ +0.8 pp
2015 54.4% CN¥7.48 Billion CN¥13.77 Billion CN¥6.28 Billion ▲ +0.4 pp
2014 54.0% CN¥8.77 Billion CN¥16.24 Billion CN¥7.47 Billion ▲ +0.7 pp
2013 53.3% CN¥8.77 Billion CN¥16.46 Billion CN¥7.68 Billion ▼ -1.9 pp
2012 55.2% CN¥8.65 Billion CN¥15.67 Billion CN¥7.02 Billion ▲ +0.2 pp
2011 55.0% CN¥6.41 Billion CN¥11.66 Billion CN¥5.25 Billion ▼ -0.6 pp
2010 55.6% CN¥6.55 Billion CN¥11.76 Billion CN¥5.22 Billion ▼ -4.2 pp
2009 59.8% CN¥5.98 Billion CN¥10.01 Billion CN¥4.02 Billion ▲ +0.0 pp
2008 59.8% CN¥5.79 Billion CN¥9.68 Billion CN¥3.89 Billion ▲ +6.3 pp
2007 53.5% CN¥5.05 Billion CN¥9.45 Billion CN¥4.40 Billion ▲ +0.6 pp
2006 52.8% CN¥4.96 Billion CN¥9.40 Billion CN¥4.43 Billion ▲ +1.9 pp
2005 50.9% CN¥4.39 Billion CN¥8.63 Billion CN¥4.24 Billion ▼ -1.2 pp
2004 52.1% CN¥3.91 Billion CN¥7.49 Billion CN¥3.59 Billion ▲ +4.6 pp
2003 47.6% CN¥3.13 Billion CN¥6.58 Billion CN¥3.45 Billion ▼ -0.8 pp
2002 48.3% CN¥2.88 Billion CN¥5.95 Billion CN¥3.08 Billion ▲ +1.9 pp
2001 46.4% CN¥2.68 Billion CN¥5.77 Billion CN¥3.09 Billion ▲ +9.9 pp
2000 36.5% CN¥1.63 Billion CN¥4.45 Billion CN¥2.82 Billion ▲ +3.1 pp
1999 33.4% CN¥1.48 Billion CN¥4.41 Billion CN¥2.94 Billion ▼ -1.7 pp
1998 35.2% CN¥1.27 Billion CN¥3.62 Billion CN¥2.34 Billion ▼ -3.4 pp
1997 38.5% CN¥1.12 Billion CN¥2.90 Billion CN¥1.78 Billion ▲ +6.8 pp
1996 31.7% CN¥788.98 Million CN¥2.49 Billion CN¥1.70 Billion ▲ +3.7 pp
1995 28.0% CN¥672.12 Million CN¥2.40 Billion CN¥1.73 Billion ▲ +0.8 pp
1994 27.2% CN¥638.52 Million CN¥2.35 Billion CN¥1.71 Billion ▲ +0.6 pp
1993 26.6% CN¥596.14 Million CN¥2.24 Billion CN¥1.64 Billion
pp = percentage points